FALZETTI, Franca
 Distribuzione geografica
Continente #
NA - Nord America 4.394
EU - Europa 2.868
AS - Asia 2.492
SA - Sud America 433
Continente sconosciuto - Info sul continente non disponibili 267
AF - Africa 71
OC - Oceania 5
Totale 10.530
Nazione #
US - Stati Uniti d'America 4.202
SG - Singapore 1.112
IT - Italia 666
IE - Irlanda 445
CN - Cina 415
BR - Brasile 332
RU - Federazione Russa 313
HK - Hong Kong 290
DE - Germania 259
VN - Vietnam 255
UA - Ucraina 248
SE - Svezia 229
FI - Finlandia 196
FR - Francia 162
GB - Regno Unito 123
KR - Corea 93
CA - Canada 72
IN - India 65
BD - Bangladesh 50
TR - Turchia 44
RO - Romania 43
MX - Messico 40
AR - Argentina 36
BE - Belgio 30
CZ - Repubblica Ceca 25
PL - Polonia 24
AT - Austria 23
IQ - Iraq 22
NL - Olanda 21
UZ - Uzbekistan 19
JP - Giappone 17
ES - Italia 16
ZA - Sudafrica 16
CO - Colombia 15
PK - Pakistan 15
GT - Guatemala 14
EC - Ecuador 13
SA - Arabia Saudita 13
CR - Costa Rica 12
ET - Etiopia 12
TT - Trinidad e Tobago 12
LT - Lituania 11
MA - Marocco 11
PH - Filippine 11
CH - Svizzera 10
CL - Cile 9
HN - Honduras 9
EG - Egitto 8
JM - Giamaica 8
VE - Venezuela 8
ID - Indonesia 7
IL - Israele 7
LB - Libano 7
MY - Malesia 7
PY - Paraguay 7
AZ - Azerbaigian 6
GP - Guadalupe 6
JO - Giordania 6
KE - Kenya 6
SV - El Salvador 6
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
OM - Oman 5
AU - Australia 4
DK - Danimarca 4
NP - Nepal 4
QA - Qatar 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
PR - Porto Rico 3
SC - Seychelles 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
DZ - Algeria 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
Totale 10.254
Città #
Singapore 791
Chandler 499
Dublin 445
San Jose 382
Ashburn 378
San Mateo 299
Hong Kong 289
Perugia 271
Boardman 157
Jacksonville 139
Council Bluffs 135
Santa Clara 131
Ann Arbor 111
Beijing 105
Munich 101
Moscow 100
Seoul 93
Princeton 87
Dong Ket 86
Medford 85
Los Angeles 80
Lauterbourg 79
Altamura 78
New York 74
Andover 69
Helsinki 63
Turku 62
Lawrence 58
Ho Chi Minh City 57
Wilmington 56
Dallas 47
Bucharest 40
São Paulo 35
Houston 34
Piscataway 34
Hanoi 33
Brussels 30
The Dalles 28
Foligno 27
Saint Petersburg 24
Izmir 23
Dearborn 22
Des Moines 22
Milan 22
Brooklyn 21
Frankfurt am Main 21
Redwood City 21
Norwalk 20
London 19
Mexico City 18
Orem 18
Shanghai 18
Rome 17
Tokyo 17
Brno 16
Toronto 16
Warsaw 16
Atlanta 15
Bologna 15
Denver 15
Phoenix 15
Montreal 14
Rio de Janeiro 13
San Francisco 13
San Paolo di Civitate 13
Chicago 12
San José 12
Chennai 11
Stockholm 11
Vienna 11
Addis Ababa 10
Assisi 10
Falkenstein 10
Falls Church 10
Florence 10
Guatemala City 10
Nuremberg 10
Redmond 10
West Jordan 10
Woodbridge 10
Boston 9
Charlotte 9
Da Nang 9
Johannesburg 9
Tashkent 9
Auburn Hills 8
Baghdad 8
Barnet 8
Groningen 8
Hefei 8
Amsterdam 7
Belo Horizonte 7
Curitiba 7
Guangzhou 7
Hải Dương 7
Lahore 7
Naples 7
New Delhi 7
Olomouc 7
Ottawa 7
Totale 6.444
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 194
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 193
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 189
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 188
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 168
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 167
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 154
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 150
Graft engineering for allogeneic haploidentical stem cell transplantation 146
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 146
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 145
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 145
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 142
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 140
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 139
"Designed" grafts for HLA-haploidentical stem cell transplantation. 134
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 133
Mesenchymal cells: a vehicle for gene therapy 132
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 132
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 131
In Vivo Real Time Monitoring of Stem Cells Homing in Postischemic Tissues 131
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 130
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 130
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 130
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 130
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 130
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 129
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 128
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 127
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 125
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 124
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 123
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 122
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 122
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 122
IN VIVO DIRECT MONITORING OF STEM CELLS HOMING IN POSTISCHEMIC TISSUES 121
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 121
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 120
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 119
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 119
T regulatory cell separation for clinical application. 118
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 114
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 113
. Mismatched hematopoietic stem cell transplants in elderly patients. 112
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 110
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era 109
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 107
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 107
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 107
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 105
Stem cell mobilization in normal donors. 105
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 104
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 103
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 103
Mismatched hematopoietic stem cell transplantation in secondary leukemia 103
Effetto della severità dell'ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicroscopia 103
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 102
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis 101
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 100
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 100
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 99
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 99
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 97
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 97
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 96
Effetto della severità dell’ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicrosopia. 95
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 95
New mechanism of lymphoma-induced bone marrow aplasia 95
MOLECULAR AND BIOLOGICAL BASIS OF THE ASOCIATION OF RADIOTHERAPY, 5-FLUOROURACIL AND GEFITINIB IN RECTAL CANCER 94
Mesenchymal cells recruit and regulate T regulatory cells. 93
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 92
Full haplotype mismatched transplant in high risk acute leukemia patients. 91
Reclutamento delle cellule staminali nei tessuti postischemici: valutazione diretta in vivo mediante videomicroscopia 91
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 91
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 90
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 86
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 83
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 82
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 81
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 81
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 81
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 80
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 78
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 78
Trapianto di cellule staminali nei tessuti post-ischemici: studio in vivo degli effetti delle cellule staminali sulla funzione microvascolare. 76
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 75
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 74
Next generation HLA-haploidentical HSCT 73
NOTCH and Graft-Versus-Host Disease 72
Radioimmunotherapy with 90Y-ibritumomab tiuxetan to treat follicular non Hodgkin-lymphoma in relapse after autologous transplant or refractory to chemotherapy: preliminary results. 70
Uno strano caso di “eritema pernio” delle mani 69
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 66
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 61
null 37
CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT 15
Totale 10.530
Categoria #
all - tutte 46.395
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022643 0 0 0 0 22 10 14 223 12 77 138 147
2022/20231.471 89 275 15 129 119 150 0 61 558 6 49 20
2023/2024746 30 69 37 29 3 20 178 9 46 38 128 159
2024/20251.523 60 141 60 76 198 52 91 98 260 85 255 147
2025/20263.145 220 201 166 411 464 322 511 143 316 296 62 33
2026/2027942 66 93 185 523 75 0 0 0 0 0 0 0
Totale 10.530